Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 15039-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#15039-1-AP, RRID:AB_10949191
- Product name
- CMTM8 antibody
- Antibody type
- Polyclonal
- Description
- CMTM8 antibody (Cat. #15039-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references The MAL Family of Proteins: Normal Function, Expression in Cancer, and Potential Use as Cancer Biomarkers.
Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer.
Downregulated CMTM8 Correlates with Poor Prognosis in Gastric Cancer Patients.
MicroRNA-582-5p promotes triple-negative breast cancer invasion and metastasis by antagonizing CMTM8.
CMTM8 inhibits the carcinogenesis and progression of bladder cancer.
Labat-de-Hoz L, Rubio-Ramos A, Correas I, Alonso MA
Cancers 2023 May 17;15(10)
Cancers 2023 May 17;15(10)
Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer.
Kang N, Xie X, Zhou X, Wang Y, Chen S, Qi R, Liu T, Jiang H
BMC gastroenterology 2022 Apr 16;22(1):190
BMC gastroenterology 2022 Apr 16;22(1):190
Downregulated CMTM8 Correlates with Poor Prognosis in Gastric Cancer Patients.
Yan M, Zhu X, Qiao H, Zhang H, Xie W, Cai J
DNA and cell biology 2021 Jun;40(6):791-797
DNA and cell biology 2021 Jun;40(6):791-797
MicroRNA-582-5p promotes triple-negative breast cancer invasion and metastasis by antagonizing CMTM8.
Zeng X, Ma X, Guo H, Wei L, Zhang Y, Sun C, Han N, Sun S, Zhang N
Bioengineered 2021 Dec;12(2):10126-10135
Bioengineered 2021 Dec;12(2):10126-10135
CMTM8 inhibits the carcinogenesis and progression of bladder cancer.
Gao D, Hu H, Wang Y, Yu W, Zhou J, Wang X, Wang W, Zhou C, Xu K
Oncology reports 2015 Dec;34(6):2853-63
Oncology reports 2015 Dec;34(6):2853-63
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- mouse liver tissue were subjected to SDS PAGE followed by western blot with 15039-1-AP(CMTM8 antibody) at dilution of 1:300
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human liver using 15039-1-AP(CMTM8 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CMTM8 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CMTM8. This antibody recognizes human, mouse, rat antigen. The CMTM8 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
